Steris (STE) Receivables (2018 - 2026)

Steris' Receivables history runs 9 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Receivables rose 4.67% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 4.67% increase from a year earlier, with the FY2026 full-year figure at $1.1 billion, up 4.67% from the prior year.
• Receivables improved to $1.1 billion in Q1 2026 per STE's latest filing, from $990.6 million in the prior quarter.
• Across five years, Receivables topped out at $1.1 billion in Q1 2026 and bottomed at $763.8 million in Q2 2022.
• The 5-year median for Receivables is $923.3 million (2024), against an average of $916.7 million.
• Across the five-year window, Receivables surged 31.12% in 2022 and retreated 5.06% in 2024, its largest moves.
• Year by year, Receivables stood at $822.8 million in 2022, then gained by 17.17% to $964.0 million in 2023, then fell by 5.06% to $915.2 million in 2024, then grew by 8.24% to $990.6 million in 2025, then rose by 10.32% to $1.1 billion in 2026.
• Per Business Quant, the three latest STE Receivables figures stand at $1.1 billion (Q1 2026), $990.6 million (Q4 2025), and $947.3 million (Q3 2025).